DCT

4:22-cv-00615

Litebook Co Ltd v. Bombardier Aerospace Corp

Log In

I. Executive Summary and Procedural Information

  • Parties & Counsel:
  • Case Identification: 4:22-cv-00615, N.D. Tex., 07/18/2022
  • Venue Allegations: Venue is alleged to be proper in the Northern District of Texas based on both Bombardier and NetJets maintaining established places of business within the district.
  • Core Dispute: Plaintiff alleges that Defendants’ premium aircraft, which feature the "Soleil" circadian lighting system, infringe a patent related to using specific wavelengths of light to regulate human melatonin production and treat light-responsive disorders like jet lag.
  • Technical Context: The technology at issue involves bio-active lighting systems designed to manipulate the human circadian system, a field with significant market application in long-haul aviation where mitigating jet lag is a key passenger comfort feature.
  • Key Procedural History: The complaint does not mention any prior litigation, Inter Partes Review (IPR) proceedings, or licensing history related to the patent-in-suit.

Case Timeline

Date Event
2000-05-10 ’140 Patent Priority Date
2010-03-16 ’140 Patent Issue Date
2022-07-18 Complaint Filing Date

II. Technology and Patent(s)-in-Suit Analysis

U.S. Patent No. 7,678,140 - "Photoreceptor System for Melatonin Regulation and Phototherapy," Issued March 16, 2010

The Invention Explained

  • Problem Addressed: The patent addresses the uncertainty regarding which specific ocular photoreceptors are responsible for regulating the human circadian system. The background section notes that clinical studies on individuals with visual impairments suggest that the photoreceptors for circadian regulation are distinct from the rods and cones that mediate vision (ʼ140 Patent, col. 3:5-25).
  • The Patented Solution: The invention claims to be based on research that established an "action spectrum" for light-induced melatonin suppression in humans. This research identified a peak sensitivity in the 446-477 nm wavelength range (blue light), which is different from the peak sensitivity of the human visual system (555 nm) ('140 Patent, col. 4:10-17). The patent describes a method of using light within a specific spectral range (435-488 nm) from a source not mounted on the body to regulate the circadian system and treat "light responsive disorders" ('140 Patent, col. 26:7-31).
  • Technical Importance: By identifying a specific, maximally effective range of light wavelengths, this approach allows for more targeted phototherapy that is potentially more efficient and may reduce side effects like glare associated with less-specific, high-intensity bright light treatments ('140 Patent, col. 21:55-62).

Key Claims at a Glance

  • The complaint asserts infringement of at least independent claim 1 (Compl. ¶32).
  • The essential elements of independent claim 1 include:
    • A method for treating or preventing a light-responsive disorder in a mammal.
    • Utilizing a light source that emits optical radiation.
    • The radiation employs a "pre-established spectral composition" that is "maximally potent" for regulating the human circadian system.
    • This composition includes at least one peak of emitted light within the range of 435-488 nm.
    • Exposing the retina to this radiation from a light source that is "not mounted on the body" of the mammal.
    • Stimulating the photoreceptor system for the circadian, photoneural, or neuroendocrine systems.
    • Enabling the treatment or prevention of the light-responsive disorder.
  • The complaint states that Plaintiff may later assert infringement of other claims of the ʼ140 Patent (Compl. ¶32).

III. The Accused Instrumentality

Product Identification

The accused instrumentalities are the Bombardier Global 7500 and Global 8000 business jets, as well as older model aircraft retrofitted with the "Soleil Lighting System" (Compl. ¶18).

Functionality and Market Context

The Soleil system is marketed as "aviation's first circadian rhythm-based cabin lighting system" (Compl. p. 2). Its function is to combat jet lag through a "Dynamic Daylight Simulation" that automatically adjusts the cabin lighting based on flight path and destination time (Compl. ¶20, p. 7). The complaint alleges the system "leverages specific combinations of red and blue light wavelengths to aid in stimulating or suppressing the production of melatonin" to synchronize a passenger's internal clock with the destination (Compl. p. 8). A diagram in the complaint shows customizable "Circadian Adjustment Setting[s]" for "Extended Work" and "Extended Sleep," indicating distinct lighting sequences are used to achieve different physiological effects (Compl. p. 7).

IV. Analysis of Infringement Allegations

Claim Chart Summary:

Claim Element (from Independent Claim 1) Alleged Infringing Functionality Complaint Citation Patent Citation
A method of at least treating or preventing at least one light responsive disorder... The Soleil Lighting System is used for "treating and preventing circadian rhythm disorders, such as the common disorientation caused by changing time zones known as ‘Jet Lag.’” ¶20 col. 8:44-50
utilizing at least one light source... emitting optical radiation; The system uses "LED lights installed in the aircraft cabin to emit optical radiation at least in the visible spectrum," as shown in a photograph of the cabin interior. ¶21, p. 8 col. 8:59-61
...employing a pre-established spectral composition... comprising at least one peak of emitted light within the range of 435-488 nm; The system allegedly uses "pre-established blue light wavelengths" and "specific combinations of blue light wavelengths." The complaint includes a scientific graph to support that the peak effectiveness for melatonin suppression (464 nm) falls within the claimed range. ¶22, ¶23, p. 9 col. 4:10-17
exposing at least a portion of the retina... such that said light source is not mounted on the body of said at least one mammal: The system uses "overhead lights to illuminate an airplane cabin for human use," which are not mounted on the passengers' bodies. ¶25 col. 26:22-25
stimulating the photoreceptor system for at least one of the circadian, photoneural or neuroendocrine systems... The system allegedly "leverages specific combinations of blue light wavelengths to stimulate the photoreceptor systems of aircraft passengers to adjust the output melatonin." ¶26 col. 8:22-25
...enabling at least the treatment or the prevention of at least one light responsive disorder... The system "aligns the body's internal clock with the time at the destination to alleviate jet lag" and enables the "minimalization of circadian rhythm disorders." ¶27, ¶28 col. 26:29-31

Identified Points of Contention:

  • Technical Questions: A primary factual dispute may center on whether the Soleil system's actual spectral output matches the claimed composition. The complaint supports its allegations with Defendants' marketing materials and scientific literature, including a graph showing peak melatonin suppression at 464 nm (Compl. p. 9). This raises the evidentiary question of whether the accused system's "blue light wavelengths" actually function as a "pre-established spectral composition" with a peak in the 435-488 nm range, or if this is a technical oversimplification of a more general lighting feature.
  • Scope Questions: The case may raise the question of whether "Jet Lag" legally constitutes a "light responsive disorder" as that term is used in the patent. While the patent defines the term to include "circadian disruption," a defendant could argue for a narrower construction limited to more formally recognized clinical conditions also mentioned in the patent, such as Seasonal Affective Disorder ('140 Patent, col. 4:26-30; col. 8:45-50).

V. Key Claim Terms for Construction

  • The Term: "pre-established spectral composition"

    • Context and Importance: This term is the technical heart of the invention. Its construction will determine whether the accused system's use of "blue light" is sufficient to infringe, or if a more specific, scientifically-derived light formula is required.
    • Evidence for a Broader Interpretation: The claim language itself is somewhat general, referring to a "maximally potent spectral composition" without being tied to a single, precise formula ('140 Patent, col. 26:15-16). A plaintiff might argue this covers any light mixture scientifically designed and pre-set to be effective for circadian regulation.
    • Evidence for a Narrower Interpretation: The specification heavily emphasizes the action spectrum experiments that identified a specific optimal range of 446-477 nm and a peak at 464 nm ('140 Patent, col. 4:10-17; Fig. 11). A defendant may argue that the term should be limited to compositions that are based on, or closely resemble, the specific action spectrum disclosed in the patent.

  • The Term: "light responsive disorder"

    • Context and Importance: This term defines the purpose and scope of the claimed method. For infringement to be found, the accused method must be used to treat or prevent a condition falling within this definition. The complaint identifies "Jet Lag" as such a disorder (Compl. ¶20).
    • Evidence for a Broader Interpretation: The patent provides a non-limiting definition that explicitly includes "circadian disruption" ('140 Patent, col. 8:46-47), which a plaintiff would argue plainly encompasses jet lag.
    • Evidence for a Narrower Interpretation: A defendant could argue the term should be understood in the context of the patent's discussion of recognized clinical conditions like Seasonal Affective Disorder (SAD) and nonseasonal depression ('140 Patent, col. 4:26-30), potentially contending that a transient condition like jet lag does not qualify as a "disorder."

VI. Other Allegations

  • Indirect Infringement: The complaint alleges inducement of infringement, asserting that Defendants actively "direct, encourage, aid and abet, and instruct" customers and passengers to use the Soleil system in an infringing manner (Compl. ¶38). Factual support includes allegations of advertising the system's benefits and providing instructions for users to customize the lighting settings (Compl. ¶¶41, 44). The complaint points to a specific high-profile user, Kylie Jenner, and provides a picture of her with an allegedly infringing aircraft to exemplify this induced use (Compl. ¶39, p. 13).
  • Willful Infringement: The complaint does not allege pre-suit knowledge of the ʼ140 Patent. However, it explicitly states that Defendants are on notice "at least as of the service of this complaint" (Compl. ¶33), thereby establishing a basis for post-filing willful infringement. The prayer for relief requests "exemplary, increased, and/or statutory damages" (Compl. p. 16).

VII. Analyst’s Conclusion: Key Questions for the Case

  • A key evidentiary question will be one of technical implementation: does the accused Soleil system's use of "blue light wavelengths" meet the claim requirement of a "pre-established spectral composition" with a peak within the 435-488 nm range? Discovery will likely focus on moving beyond marketing claims to the system's actual, engineered spectral output.
  • The case will also turn on a question of claim construction: will the court interpret "pre-established spectral composition" broadly to encompass any lighting system using blue light to target the circadian system, or narrowly to require a composition closely matching the specific action spectrum disclosed in the patent? The outcome of this construction will significantly influence the infringement analysis.